article thumbnail

5 Ways AI Is Innovating Preventative Care

HIT Consultant

AI Wearable Technology Wearable health technology isnt new, but its come a long way since it was first implemented. Smart Pharmacies AIs data analyzing and automation skills have a lot of power in pharmaceutical settings, too. AI in the pharmaceutical sector can keep patients healthier.

article thumbnail

The Gains and Pains of Using AI in the Pharmaceutical Industry

HIT Consultant

Contributing factors to this included larger trial sizes, the need to assess health technology, the requirement to provide data on comparative drugs’ effectiveness, and most importantly the high failure rate. A study in 2020 concluded that the estimated median capitalized research and development cost per product was $985 million.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

article thumbnail

The Pandemic Treaty and Intellectual Property Sharing: Making Vaccine Knowledge a Public Good 

Bill Of Health

The Pandemic Treaty (or other legal instrument) scheduled for discussion at the World Health Assembly in the fall of 2021 should focus on establishing the norm that the IP and knowledge needed to develop and produce essential pandemic health technologies become global public goods. and German governments in particular.

article thumbnail

Bone Health Technologies Acquires Wellen to Deliver Personalized, Non-Drug Osteoporosis Care

HIT Consultant

A Comprehensive Solution Anchored by Innovation This acquisition positions BHT to achieve its vision of a holistic bone health solution. The Wellen program will bring tremendous value to our platform,” said Laura Yecies , CEO of Bone Health Technologies.

article thumbnail

Tuva Health Raises $5M for Open-Source Healthcare Data Platform

HIT Consultant

What You Should Know: – Tuva Health, the world’s first open-source healthcare data transformation platform, launched out of stealth today with $5M in seed funding. Investments in commercial initiatives and product development to drive innovation and scalability.

article thumbnail

Book Review: The Right Price

Healthcare ECONOMIST

That the book should be able to so clearly elucidate these issues should not come as a surprise as the authors–Peter Neumann, Joshua Cohen and Daniel Ollendorf–are pre-eminent experts in value-based pricing methodologies for pharmaceuticals. Are high drug prices a good thing? PBMs: The problem or the solution. The spread of HTA.

article thumbnail

What is HEMA?

Healthcare ECONOMIST

The Pink Sheet reports on a new international health technology assessment (HTA) body: Health Economics Methods Advisory group (HEMA). Provide recommendations to the HTA community regarding adoption of novel methods, modifications that might be required, uncertainties in methods application, and suggestions for further research.